Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Medicines Company (MDCO)

2014-10-31@08:11:22 ET
Medicines Company announces encouraging results from Phase III hemostasis trial (DTM)

2014-10-31@05:20:37 ET
Form 144: Filing to Sell 18731 Shares of Medicines Co (MDCO) (VKR)

2014-10-30@16:03:01 ET
The Medicines Company to Webcast Investor & Analyst Day on November 5 (BIZ)

2014-10-30@14:50:52 ET
Potential Medicines (MDCO) Trade Has 9.14% Downside Protection (FBM)

2014-10-30@11:43:47 ET
Highest Future Earnings Growth in the Pharmaceuticals Industry Detected for Sucampo Pharmaceuticals (SCMP, DEPO, MDCO) (F70)

2014-10-30@08:35:15 ET
Sanofi-Aventis had the Lowest Relative Performance in the Pharmaceuticals Industry (SNY, MDCO, MYL, ENDP, NVS) (F70)

2014-10-29@15:58:25 ET
Medicines (MDCO) Showing Resistance Near $26.57 (FBM)

2014-10-29@08:27:34 ET
Shares of Medicines Co Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (MDCO, NKTR, DEPO, NVS, JAZZ) (F70)

2014-10-28@12:46:53 ET
Medicines (MDCO) Showing Support Near $21.32 (FBM)

2014-10-28@11:30:08 ET
The Medicines Company Announces Presentation of Investigational Hemostatic Agent RAPLIXA(TM) (fibrin sealant) Phase III FINISH-3 Trial Results at the 2014 Clinical Conference of the American College of Surgeons (BIZ)

2014-10-28@11:15:55 ET
Medicines Co Shares Climbing Higher, Up 13.7% (F77)

2014-10-28@08:22:12 ET
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (NKTR, RPRX, MDCO, VRX, AZN) (F70)

2014-10-28@08:01:10 ET
Alnylam and The Medicines Company Announce Filing of a Clinical Trial Application to Initiate a Phase 1 Study for ALN-PCSsc, an Investigational, Subcutaneously Administered RNAi Therapeutic Targeting PCSK9 for the Treatment of Hypercholesterolemia (BIZ)

2014-10-28@05:12:15 ET
Medicines Company reports net loss for Q3 (DTM)